DE69125969T2 - Arzneimittel zur Behandlung zentraler neuro-degenerativer Erkrankungen - Google Patents
Arzneimittel zur Behandlung zentraler neuro-degenerativer ErkrankungenInfo
- Publication number
- DE69125969T2 DE69125969T2 DE69125969T DE69125969T DE69125969T2 DE 69125969 T2 DE69125969 T2 DE 69125969T2 DE 69125969 T DE69125969 T DE 69125969T DE 69125969 T DE69125969 T DE 69125969T DE 69125969 T2 DE69125969 T2 DE 69125969T2
- Authority
- DE
- Germany
- Prior art keywords
- medicines
- treatment
- neurodegenerative diseases
- central neurodegenerative
- central
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14770990 | 1990-06-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69125969D1 DE69125969D1 (de) | 1997-06-12 |
DE69125969T2 true DE69125969T2 (de) | 1997-09-25 |
Family
ID=15436447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69125969T Expired - Fee Related DE69125969T2 (de) | 1990-06-06 | 1991-02-28 | Arzneimittel zur Behandlung zentraler neuro-degenerativer Erkrankungen |
Country Status (6)
Country | Link |
---|---|
US (1) | US5155129A (de) |
EP (1) | EP0460358B1 (de) |
JP (1) | JP3089040B2 (de) |
CA (1) | CA2037188A1 (de) |
DE (1) | DE69125969T2 (de) |
HU (1) | HUT57583A (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5401850A (en) * | 1990-06-06 | 1995-03-28 | Suntory Limited | Cyclopropachromen derivatives |
JP3993651B2 (ja) * | 1994-10-21 | 2007-10-17 | アスビオファーマ株式会社 | シクロプロパクロメンカルボン酸誘導体 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0723367B2 (ja) * | 1986-02-27 | 1995-03-15 | サントリー株式会社 | オキサビシクロヘプタン誘導体 |
-
1991
- 1991-02-27 CA CA002037188A patent/CA2037188A1/en not_active Abandoned
- 1991-02-27 JP JP03033031A patent/JP3089040B2/ja not_active Expired - Fee Related
- 1991-02-28 HU HU91677A patent/HUT57583A/hu unknown
- 1991-02-28 US US07/662,105 patent/US5155129A/en not_active Expired - Fee Related
- 1991-02-28 DE DE69125969T patent/DE69125969T2/de not_active Expired - Fee Related
- 1991-02-28 EP EP91103040A patent/EP0460358B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0460358A3 (en) | 1992-10-07 |
HU910677D0 (en) | 1991-09-30 |
EP0460358A2 (de) | 1991-12-11 |
EP0460358B1 (de) | 1997-05-07 |
DE69125969D1 (de) | 1997-06-12 |
JPH04235127A (ja) | 1992-08-24 |
JP3089040B2 (ja) | 2000-09-18 |
HUT57583A (en) | 1991-12-30 |
US5155129A (en) | 1992-10-13 |
CA2037188A1 (en) | 1991-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69315257D1 (de) | Simethicon enthaltende Arzneimittel zur Behandlung gastrointestinaler Störungen | |
DE69630479D1 (de) | Arzneimittel zur Behandlung von entzündlichen Herzkrankheiten | |
NO924461D0 (no) | Dipyridamol for behandling av proliferaktive sykdommer | |
DE3775805D1 (de) | Arzneimittel zur behandlung periodontaler erkrankungen. | |
DE69124293D1 (de) | Vorrichtung zur Behandlung von Wirbelsäulenerkrankungen | |
NO971816D0 (no) | Farmasöytisk blanding for behandling av sykdommer forårsaket av IL-6 produksjon | |
NO965377L (no) | Indolinonforbindelser for behandling av sykdommer | |
ATE201992T1 (de) | Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen | |
DE69532066D1 (de) | Arzneimittel zur Behandlung von Restenosis und Gefässsklerose | |
NO953254D0 (no) | Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter | |
DE69600983D1 (de) | Kapselpräparate zur Behandlung von Pflanzen | |
NO833279L (no) | Farmasoeytiske preparater for behandling av uoensket sammenvoksing | |
DE69420229T2 (de) | Pharmazeutische Zusammensetzung zur Behandlung von AIDS | |
EE9700235A (et) | Benseenamiidid neurodegeneratiivsete haiguste ravimiseks | |
NO913117L (no) | Fremgangsmaate for behandling av benoedeleggende sykdommer. | |
DK101197A (da) | Medikament til behandling af thrombocytopenia | |
DE69739190D1 (de) | Arzneimittel zur behandlung von oculären kreislauferkrankungen | |
DE69125969T2 (de) | Arzneimittel zur Behandlung zentraler neuro-degenerativer Erkrankungen | |
DK10188D0 (da) | Middel til behandling af virussygdomme | |
DE69840432D1 (de) | Arzneimittel zur behandlung der augen | |
EP0457671A3 (en) | Dipyridamide for the treatment of diseases of the central or peripheral nervous system | |
PT84996A (de) | Pharmazeutische zubereitung zur behandlung bakterieller infektionen | |
FI102810B1 (fi) | Aine eläimen ihon käsittelyyn | |
DE19775036I2 (de) | Arzneimittel zur Behandlung von Augenentzündung. | |
ATE336282T1 (de) | Katheter zur behandlung von prostaterkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |